{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:04:44Z","timestamp":1787497484448,"version":"build-2736575974"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.tox.2019.01.012","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T14:19:00Z","timestamp":1548253140000},"page":"62-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Prophylactic potential of memantine against soman poisoning in rats"],"prefix":"10.1016","volume":"416","author":[{"given":"Milo\u0161 P.","family":"Stojiljkovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranko","family":"\u0160krbi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Jokanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravko","family":"Bokonji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Kilibarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Vulovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2019.01.012_bib0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15376516.2016.1197992","article-title":"Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats","volume":"26","author":"Acon-Chen","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.tox.2019.01.012_bib0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(25)08651-3","article-title":"Pharmacological action of some analogues of physostigmine","volume":"43","author":"Aeschlimann","year":"1931","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0015","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1073\/pnas.0605370103","article-title":"Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents","volume":"103","author":"Albuquerque","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2019.01.012_bib0020","first-page":"121","article-title":"Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase","volume":"43","author":"Allon","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01480549109017866","article-title":"Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure","volume":"14","author":"Anderson","year":"1991","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3121\/cmr.2007.701","article-title":"Unequal efficacy of pyridinium oximes in acute organophosphate poisoning","volume":"5","author":"Antonijevi\u0107","year":"2007","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2298\/VSP1112033A","article-title":"Antidotal effect of combinations obidoxime\/HI-6 and memantine in mice poisoned with soman, dichlorvos or heptenophos","volume":"68","author":"Antonijevi\u0107","year":"2011","journal-title":"Vojnosanit. Pregl."},{"key":"10.1016\/j.tox.2019.01.012_bib0040","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/0024-3205(86)90361-9","article-title":"Clonidine protection from soman and echothiophate toxicity in mice","volume":"39","author":"Aronstam","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0045","series-title":"Analysis of Biogenic Amines and Their Related Enzymes.","first-page":"217","article-title":"Determination of activity of cholinesterase","author":"Augustinsson","year":"1971"},{"key":"10.1016\/j.tox.2019.01.012_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","article-title":"Organophosphates\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment","volume":"38","author":"Bajgar","year":"2004","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.tox.2019.01.012_bib0055","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2174\/092986709788803088","article-title":"Chemical aspects of pharmacological prophylaxis against nerve agent poisoning","volume":"16","author":"Bajgar","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2019.01.012_bib0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0006-2952(70)90256-X","article-title":"The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate","volume":"19","author":"Berry","year":"1970","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-2952(71)90478-3","article-title":"Protection of animals against soman (1,2,2-trimethylpropyl methylphosphonofluoridate) by pretreatment with some other organophosphorus compounds, followed by oxime and atropine","volume":"20","author":"Berry","year":"1971","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0070","first-page":"393","article-title":"Excretion and metabolism of 14C-pyridostigmine in the rat","volume":"26","author":"Birtley","year":"1966","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0075","first-page":"309","article-title":"Protective effect of the oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphos-poisoned rats","volume":"288","author":"Bokonji\u0107","year":"1987","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(89)90385-3","article-title":"Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels","volume":"166","author":"Bormann","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0085","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0272-0590(81)80059-0","article-title":"The treatment of soman poisoning and its perspectives","volume":"1","author":"Bo\u0161kovi\u0107","year":"1981","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0090","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/0272-0590(84)90142-8","article-title":"PAM-2 Cl, HI-6, and HGG-12 in soman and tabun poisoning","volume":"4","author":"Bo\u0161kovi\u0107","year":"1984","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0361-9230(89)90173-1","article-title":"MK-801 protects against seizures induced by cholinesterase inhibitor soman","volume":"23","author":"Braitman","year":"1989","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tox.2019.01.012_bib0100","first-page":"251","article-title":"Adamantane derivatives as potential reactivators of acetylcholinesterase inhibited by organophosphorus compounds","volume":"42","author":"Bregovec","year":"1992","journal-title":"Acta Pharm."},{"key":"10.1016\/j.tox.2019.01.012_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0160-5402(88)90042-3","article-title":"Phrenic nerve-diaphragm preparation in situ for studying the detoxification of soman in the rat liver","volume":"19","author":"\u0106etkovi\u0107","year":"1988","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.tox.2019.01.012_bib0110","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/0272-0590(84)90143-X","article-title":"Effect of PAM-2 Cl, HI-6, and HGG-12 in poisoning by tabun and its thiocholine-like analog in the rat","volume":"4","author":"\u0106etkovi\u0107","year":"1984","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0041-008X(79)90325-9","article-title":"Efficacy of pro-PAM (N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride) as a prophylaxis against organophosphate poisoning","volume":"47","author":"Clement","year":"1979","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0272-0590(81)80058-9","article-title":"Toxicology and pharmacology of bispyridinium oximes \u2013 insight into the mechanism of action vs soman poisoning in vivo","volume":"1","author":"Clement","year":"1981","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0041-008X(82)90332-5","article-title":"HI-6, an oxime which is an effective antidote of soman poisoning: a structure activity study","volume":"64","author":"Clement","year":"1982","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15287398809531175","article-title":"Effects of phenytoin, ketamine, and atropine methyl nitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and diisopropylphosphofluoridate","volume":"24","author":"Clinton","year":"1988","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.tox.2019.01.012_bib0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00437615","article-title":"Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan)","volume":"43","author":"Costall","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.tox.2019.01.012_bib0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-3565(25)26312-1","article-title":"Adjunctive value of oral prophylaxis with the oximes 2-PAM lactate and 2-PAM methanesulfonate to therapeutic administration of atropine in dogs poisoned by inhaled sarin vapor","volume":"136","author":"Crook","year":"1962","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jat.2550140502","article-title":"Review of oximes available for treatment of nerve agent poisoning","volume":"14","author":"Dawson","year":"1994","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0150","first-page":"1071","article-title":"Sarin and paraoxon antagonism in different species","volume":"35","author":"DeCandole","year":"1957","journal-title":"Can. J. Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0272-0590(86)90231-9","article-title":"Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning","volume":"6","author":"Deshpande","year":"2019","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-0590(81)80061-9","article-title":"The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against soman poisoning in vivo","volume":"1","author":"Deyi","year":"1981","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.2042-7158.1978.tb13278.x","article-title":"Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman","volume":"30","author":"Dirnhuber","year":"1978","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.2042-7158.1979.tb13504.x","article-title":"The protection of primates against soman poisoning by pretreatment with pyridostigmine","volume":"31","author":"Dirnhuber","year":"1979","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cbi.2010.02.021","article-title":"In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity","volume":"187","author":"diTargiani","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2019.01.012_bib0180","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0024-3205(85)90496-5","article-title":"Effects of diazepam on soman-induced brain neuronal RNA depletion and lethality in rats","volume":"36","author":"Doebler","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2005.06.013","article-title":"Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus","volume":"1051","author":"Dorandeu","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.1989.03430050065028","article-title":"Progress in medical defense against nerve agents","volume":"262","author":"Dunn","year":"1989","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tox.2019.01.012_bib0195","first-page":"4","article-title":"Pyridostigmine \u2013 product profile","volume":"2","author":"Duphar","year":"2019","journal-title":"Med. Corp. Int."},{"key":"10.1016\/j.tox.2019.01.012_bib0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholine esterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(88)90201-X","article-title":"Immunoaffinity purification of human erythrocyte prolidase","volume":"176","author":"Endo","year":"1988","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tox.2019.01.012_bib0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(91)90625-Z","article-title":"Memantine is highly potent in protecting cortica cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate","volume":"198","author":"Erd\u00f6","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0215","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01427.x","article-title":"Neuroprotective efficacy of caramiphen against soman and mechanisms of its action","volume":"164","author":"Figueiredo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0220","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0006-2952(65)90082-1","article-title":"Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate","volume":"14","author":"Fleisher","year":"1965","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0225","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0041-008X(88)90357-2","article-title":"Protection against diisopropylfluorophosphate intoxication by meptazinol","volume":"95","author":"Galli","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0230","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01968968","article-title":"Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication","volume":"65","author":"Galli","year":"1991","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.2042-7158.1985.tb04928.x","article-title":"In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates","volume":"37","author":"Galli","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0272-0590(90)90204-W","article-title":"Assessing the efficacy of azaprophen and physostigmine as a pretreatment for soman-induced incapacitation in guinea pigs by response surface modeling","volume":"14","author":"Gennings","year":"1990","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0041-008X(78)80045-3","article-title":"The protection of animals against organophosphate poisoning by pretreatment with a carbamate","volume":"43","author":"Gordon","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0250","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/0006-2952(83)90115-6","article-title":"A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compounds","volume":"32","author":"Green","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0255","first-page":"649","article-title":"Potential of memantine, d-tubocurarine and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX","volume":"13","author":"Gupta","year":"1992","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/15287398909531332","article-title":"Prevention and antagonism of acute carbofuran intoxication by memantine and atropine","volume":"28","author":"Gupta","year":"1989","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.tox.2019.01.012_bib0265","first-page":"208","article-title":"Methyl parathion toxicity: prophylaxis and therapy with memantine and atropine","volume":"305","author":"Gupta","year":"1990","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0270","first-page":"671","article-title":"Subchronic toxicity of aldicarb: protection and reversal by memantine and atropine","volume":"5","author":"Gupta","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.tox.2019.01.012_bib0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ddr.430240404","article-title":"Novel effects of memantine in antagonizing acute aldicarb toxicity: mechanistic and applied considerations","volume":"24","author":"Gupta","year":"1991","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0280","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ddr.430240405","article-title":"Subacute toxicity of aldicarb: prevention and treatment with memantine and atropine","volume":"24","author":"Gupta","year":"1991","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0285","first-page":"1103","article-title":"Prophylaxis and treatment against toxicity of organophosphate (OP) compounds in rat by memantine and atropine","volume":"7","author":"Gupta","year":"1987","journal-title":"Toxicologist"},{"key":"10.1016\/j.tox.2019.01.012_bib0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cbi.2008.04.033","article-title":"Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase","volume":"175","author":"Haigh","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2019.01.012_bib0295","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s11064-016-2120-9","article-title":"Time course, behavioral safety, and protective efficacy of centrally active reversible acetylcholinesterase inhibitors in cynomolgus macaques","volume":"42","author":"Hamilton","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00504993","article-title":"Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigminein combination with atropine and mecamylamine","volume":"327","author":"Harris","year":"1984","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0305","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0024-3205(80)90617-7","article-title":"The effects of pretreatment with carbamates, atropine and mecamylamine on survival and on soman-induced alterations in rat and rabbit brain acetylcholine","volume":"26","author":"Harris","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0310","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/01480548409042823","article-title":"Protection against both lethal and behavioral effects of soman","volume":"7","author":"Harris","year":"1984","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0315","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0272-0590(81)80054-1","article-title":"Therapeutic effects of new oximes, benactyzine and atropine in soman poisoning: part II. Effect of HGG-12, HGG-42, and obidoxime in poisoning with various anticholinesterase agents in beagle dogs","volume":"1","author":"Hauser","year":"1981","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/01480548009002226","article-title":"Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman","volume":"3","author":"Heyl","year":"1980","journal-title":"Drug. Chem. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0325","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.2042-7158.1983.tb04316.x","article-title":"The efficacy of bispyridinium derivatives in the treatment of organphosphonate poisoning in the guinea-pig","volume":"35","author":"Inns","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0330","series-title":"Clinical and Experimental Toxicology of Organophosphates and Carbamates","first-page":"602","article-title":"Prophylaxis against anticholinesterase poisoning","author":"Inns","year":"1992"},{"key":"10.1016\/j.tox.2019.01.012_bib0335","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.toxlet.2015.01.007","article-title":"Developments in alternative treatments for organophosphate poisoning","volume":"233","author":"Iyer","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2019.01.012_bib0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.pbb.2005.06.017","article-title":"Anticholinesterase (DFP) toxicity antagonism by chronic donepezil: a potential nerve agent treatment","volume":"81","author":"Janowsky","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tox.2019.01.012_bib0345","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jlac.18641290114","article-title":"\u00dcber die Bohne von Calabar","volume":"129","author":"Jobst","year":"1864","journal-title":"Ann. Chem. Pharm."},{"key":"10.1016\/j.tox.2019.01.012_bib0350","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2006.09.054","article-title":"Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning","volume":"553","author":"Jokanovi\u0107","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0355","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1021\/ja01307a051","article-title":"Studies in the indol series. V. Complete synthesis of physostigmine (eserine)","volume":"51","author":"Julian","year":"1935","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tox.2019.01.012_bib0360","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/0272-0590(84)90151-9","article-title":"Ferrocene-carbamate as a prophylaxis against soman poisoning","volume":"4","author":"Karlsson","year":"1984","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0365","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0300-483X(02)00219-6","article-title":"A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun poisoned rats and mice","volume":"177","author":"Kassa","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0370","doi-asserted-by":"crossref","DOI":"10.1002\/syn.890020205","article-title":"Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation","volume":"2","author":"Kawabuchi","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.tox.2019.01.012_bib0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0041-008X(89)90058-6","article-title":"The reversible carbamate, (-)physostigmine, reduces the size of synaptic end plate lesions induced by sarin, an irreversible organophosphate","volume":"97","author":"Kawabuchi","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0380","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/0024-3205(87)90474-7","article-title":"Distribution of physostigmine and metabolites in brain subcellular fractions of the rat","volume":"41","author":"King","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0385","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-3565(25)05920-8","article-title":"Protection of cholinesterase against irreversible inactivation by di-isopropyl fluorophosphate in vitro","volume":"88","author":"Koelle","year":"1946","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.febslet.2004.06.028","article-title":"Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver","volume":"570","author":"Kondo","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tox.2019.01.012_bib0395","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0014-2999(89)90384-1","article-title":"Memantine displaces (3H)MK-801 at therapeutic concentrations in postmortem human frontal cortex","volume":"166","author":"Kornhuber","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0922-4106(91)90113-V","article-title":"Effects of 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study","volume":"206","author":"Kornhuber","year":"1991","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol. Sect."},{"key":"10.1016\/j.tox.2019.01.012_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-3565(25)05875-6","article-title":"Synergism and antagonism between physostigmine and di-isopropyl fluorophosphate in cats","volume":"88","author":"Koster","year":"1946","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0410","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2174\/13895575113136660108","article-title":"Prophylaxis and post-exposure treatment of intoxications caused by nerve agents and organophosphorus pesticides","volume":"13","author":"Kuca","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"February 1","key":"10.1016\/j.tox.2019.01.012_bib0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40360-018-0196-3","article-title":"A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase","volume":"19","author":"Kuca","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0420","first-page":"683","article-title":"When all else fails","volume":"24","author":"Leadbeater","year":"1988","journal-title":"Chem. Br."},{"key":"10.1016\/j.tox.2019.01.012_bib0425","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0272-0590(85)90132-0","article-title":"Treatment of poisoning with soman","volume":"5","author":"Leadbeater","year":"1985","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0430","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0024-3205(85)90513-2","article-title":"Relationship between reversible acetyl-cholinesterase inhibition and efficacy against soman lethality","volume":"37","author":"Lennox","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0435","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/0272-0590(84)90148-9","article-title":"Studies using a monoclonal antibody against soman","volume":"4","author":"Lenz","year":"1984","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2006.11.066","article-title":"Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review","volume":"233","author":"Lenz","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0445","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0041-008X(83)90334-4","article-title":"Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat","volume":"71","author":"Ligtenstein","year":"1983","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0450","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0041-008X(88)90392-4","article-title":"In vivo distribution of organophosphate antidotes: autoradiography of [14C]HI-6 in the rat","volume":"92","author":"Ligtenstein","year":"1988","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0455","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0272-0590(91)90088-L","article-title":"Trihexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea pigs","volume":"16","author":"Lim","year":"1991","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0460","first-page":"49","article-title":"Effect of small doses of clonazepam upon soman-induced seizure activity and convulsions","volume":"210","author":"Lipp","year":"1974","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0465","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"July","key":"10.1016\/j.tox.2019.01.012_bib0470","first-page":"19","article-title":"Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review","author":"Lorke","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0475","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0014-2999(94)90514-2","article-title":"Over-additive anticonvulsant effect of memantine and NBQX in kindled rats","volume":"259","author":"L\u00f6scher","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0480","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tox.2006.08.012","article-title":"Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning","volume":"228","author":"Luci\u0107 Vrdoljak","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0485","first-page":"64","article-title":"Gamma aminobutyric acid metabolism in different areas of rat brain at the onset of soman-induced convulsions","volume":"234","author":"Lundy","year":"1978","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0490","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0022-3565(25)10406-0","article-title":"Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro","volume":"263","author":"Lupp","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"II","key":"10.1016\/j.tox.2019.01.012_bib0495","first-page":"1256","article-title":"Die Wirkung von Memantin auf zentrale neurotransmittersysteme","volume":"32","author":"Maj","year":"1982","journal-title":"Eine Zusammenfassung der Ergebnisse. Arzneimittelforsch.\/Drug Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(74)90067-3","article-title":"Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantine derivative","volume":"26","author":"Maj","year":"1974","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0505","first-page":"335","article-title":"Biologically active adamantine derivatives","volume":"27","author":"Majerski","year":"1976","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"10.1016\/j.tox.2019.01.012_bib0510","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2011.07.001","article-title":"Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance","volume":"32","author":"Mamczarz","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0515","series-title":"Chemical Warfare Agents: Toxicology and Treatment","author":"Marrs","year":"1996"},{"key":"10.1016\/j.tox.2019.01.012_bib0520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(86)90267-0","article-title":"Effects of memantine on the frog neuromuscular junction","volume":"130","author":"Masuo","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0525","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(25)22225-X","article-title":"Effect of carboxylase inhibition on carbamate protection against soman toxicity","volume":"246","author":"Maxwell","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0530","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0041-008X(92)90365-Y","article-title":"Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase","volume":"115","author":"Maxwell","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0535","first-page":"513","article-title":"In vitro electrophysiological evidence predicting anticonvulsant efficacy of memantine and flunarizine","volume":"39","author":"McLean","year":"1987","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.tox.2019.01.012_bib0540","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0041-008X(92)90284-Y","article-title":"Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat","volume":"112","author":"McLean","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0545","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.taap.2015.02.008","article-title":"A rat model of nerve agent exposure applicable to the pediatric population: the anticonvulsant efficacies of atropine and GluK1 antagonists","volume":"284","author":"Miller","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0550","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0041-008X(87)90158-X","article-title":"Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase","volume":"89","author":"Misulis","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0555","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neubiorev.2016.10.017","article-title":"Pretreatment and prophylaxis against nerve agent poisoning: are undesirable behavioral side effects unavoidable?","volume":"71","author":"Myhrer","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tox.2019.01.012_bib0560","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuro.2009.10.002","article-title":"Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman","volume":"31","author":"Myhrer","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0565","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-3565(25)26007-4","article-title":"Efficacy and limitations of oxime-atropine treatment of organophosphorus acetylcholinesterase poisoning","volume":"132","author":"O\u2019Leary","year":"1961","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tox.2019.01.012_bib0570","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00577721","article-title":"Pyridinium und Imidazolinium-Salze als Antidote gegen\u00fcber Soman- und Paraoxonvergiftungen bei M\u00e4use","volume":"26","author":"Oldiges","year":"1970","journal-title":"Arch. Toxikol."},{"key":"10.1016\/j.tox.2019.01.012_bib0575","first-page":"119","article-title":"Effect of HI-6 on rat brain acetylcholinesterase inhibited by soman and VX in vivo","volume":"32","author":"Panteli\u0107","year":"1982","journal-title":"Acta Pharm. Jugoslav."},{"key":"10.1016\/j.tox.2019.01.012_bib0580","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0300-483X(88)90104-7","article-title":"Prevention of diisopropylphosphorofluoridate (DFP)-incuced skeletal muscle fiber lesions in rat","volume":"48","author":"Patterson","year":"1988","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2019.01.012_bib0585","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1523\/JNEUROSCI.1181-16.2016","article-title":"Neuromuscular NMDA receptors modulate developmental synapse elimination","volume":"36","author":"Personius","year":"2016","journal-title":"J. Neurosci."},{"issue":"57","key":"10.1016\/j.tox.2019.01.012_bib0590","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/toxsci\/57.1.16","article-title":"Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism","author":"Petrikovics","year":"2000","journal-title":"Toxicol. Sci."},{"issue":"June 2","key":"10.1016\/j.tox.2019.01.012_bib0595","first-page":"29","article-title":"Organophosphorus poisoning in animals and enzymatic antidotes","author":"Poirier","year":"2018","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0600","first-page":"1349","article-title":"Procyclidine protects against soman neurotoxicity, even when administered after onset of convulsions","volume":"15","author":"Price","year":"1989","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.tox.2019.01.012_bib0605","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/00039896.1968.10665158","article-title":"Feasibility of prophylaxis by oral pralidoxime","volume":"16","author":"Quinby","year":"1968","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.tox.2019.01.012_bib0610","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9343(55)80006-X","article-title":"Pharmacology of the anticholinesterase drugs - mestinon, prostigmin, tensilon and TEPP","volume":"16","author":"Randall","year":"1955","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tox.2019.01.012_bib0615","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/0006-2952(93)90228-O","article-title":"Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization","volume":"45","author":"Raveh","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0620","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0272-0590(91)90111-G","article-title":"A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-\u03b43-tetrahydropyridine]: anticholinesterase properties and efficacy against soman","volume":"16","author":"Ray","year":"1991","journal-title":"Fundam. Appl. Toxicol."},{"issue":"May 5","key":"10.1016\/j.tox.2019.01.012_bib0625","article-title":"Human butyrylcholinesterase efficacy against nerve agent exposure","volume":"1","author":"Reed","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0630","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01759955","article-title":"Zur Pathogenese und Therapie der myasthenia gravis pseudoparalytica","volume":"128","author":"Remen","year":"1932","journal-title":"Dtsch. Z. Nervenheilk."},{"key":"10.1016\/j.tox.2019.01.012_bib0635","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/milmed\/152.1.35","article-title":"Medical defense against nerve agents: new directions","volume":"152","author":"Rickett","year":"1987","journal-title":"Milit. Med."},{"key":"10.1016\/j.tox.2019.01.012_bib0640","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0773.1990.tb00824.x","article-title":"Immunologic protection against VX intoxication in experimental animals","volume":"67","author":"Rong","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0645","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2013.12.010","article-title":"Protection against paraoxon toxicity by an intravenous pretreatment with polyethylene-glycol-conjugated recombinant butyrylcholinesterase in macaques","volume":"210","author":"Rosenberg","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2019.01.012_bib0650","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bcp.2010.09.007","article-title":"Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX","volume":"81","author":"Saxena","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0655","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cbi.2015.07.001","article-title":"Prophylaxis with human serum butyrylcholinesterase protects G\u00f6ttingen minipigs exposed to a lethal high-dose of sarin vapor","volume":"238","author":"Saxena","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2019.01.012_bib0660","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/0272-0590(85)90117-4","article-title":"The protective effect of oxime pretreatment upon the inhalative toxicity of sarin and soman in rats","volume":"5","author":"Schoene","year":"1985","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0665","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(92)90243-Z","article-title":"N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of memantine in rats","volume":"143","author":"Schwarz","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tox.2019.01.012_bib0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(90)90206-L","article-title":"Neuroprotective effect of memantine demonstrated in vivo and in vitro","volume":"185","author":"Seif el Nasr","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0675","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/08958370490442511","article-title":"Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: determination of blood and brain cholinesterase activities","volume":"16","author":"\u0160evalova","year":"2004","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0680","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF01974071","article-title":"Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats","volume":"67","author":"Shih","year":"1993","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0685","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0149-7634(05)80028-4","article-title":"Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms","volume":"15","author":"Shih","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tox.2019.01.012_bib0690","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4274(91)90128-S","article-title":"A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning","volume":"55","author":"Shih","year":"1991","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2019.01.012_bib0695","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0700","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1139\/y86-178","article-title":"Effects of subchronic pyridostigmine pretreatment on the toxicity of soman","volume":"64","author":"Shiloff","year":"1986","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0705","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0773.1993.tb01334.x","article-title":"Efficacy of antidotes against soman poisoning in female physostigmine-protected rats","volume":"72","author":"Sket","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0710","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0028-3908(86)90065-1","article-title":"Effect of HI-6, applied into cerebral ventricles, on the inhibition of brain acetylcholinesterase by soman in rats","volume":"25","author":"Sket","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tox.2019.01.012_bib0715","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12031-009-9253-0","article-title":"Protection against sarin-induced seizures in rats by direct brain microinjection of scopolamine, midazolam or MK-801","volume":"40","author":"Skovira","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.tox.2019.01.012_bib0720","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bcpt.12745","article-title":"Naloxone antagonizes soman-induced central respiratory depression in rats","volume":"120","author":"\u0160krbi\u0107","year":"2017","journal-title":"Basic Clic. Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0725","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/jps.2600580730","article-title":"Comparison of two methods for measuring drug-induced neurotoxicity","volume":"58","author":"Sofia","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2019.01.012_bib0730","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0041-008X(90)90038-V","article-title":"Evaluation of a two-drug combination pretreatment against organophosphorus exposure","volume":"102","author":"Solana","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0735","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0272-0590(90)90197-R","article-title":"Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure","volume":"15","author":"Solana","year":"1990","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0740","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdd.2510100208","article-title":"Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration","volume":"10","author":"Somani","year":"1989","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.tox.2019.01.012_bib0745","first-page":"367","article-title":"Physostigmine \u2013 an overview as pretreatment drug for organophosphate intoxication","volume":"27","author":"Somani","year":"1989","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0750","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0272-0590(86)90247-2","article-title":"Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration","volume":"6","author":"Somani","year":"1986","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0755","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0028-3908(92)90068-Z","article-title":"Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman","volume":"31","author":"Sparenborg","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tox.2019.01.012_bib0760","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0006-2952(88)90202-X","article-title":"In vivo protection against soman toxicity by known inhibitors of acetylcholine synthesis in vitro","volume":"37","author":"Sterling","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0765","first-page":"435","article-title":"Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors","volume":"57","author":"Stojiljkovi\u0107","year":"2006","journal-title":"Arh. Hig. Rada Toksikol."},{"issue":"Suppl. 7","key":"10.1016\/j.tox.2019.01.012_bib0770","first-page":"139","article-title":"Relative therapeutic efficacy of anticholinergic drugs in the treatment of acute physostigmine intoxications in rats","volume":"25","author":"Stojiljkovi\u0107","year":"1989","journal-title":"Iugoslav. Physiol. Pharmacol. Acta"},{"key":"10.1016\/j.tox.2019.01.012_bib0775","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0272-0590(87)90112-6","article-title":"Potentiations of N-methylcarbamate toxicities by organophosphorus insecticides in male mice","volume":"8","author":"Takahashi","year":"1987","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0780","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(89)90662-6","article-title":"Effects of memantine on the twitch tension of mouse diaphragm","volume":"160","author":"Tsai","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0785","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1006\/taap.1996.0232","article-title":"Eptastigmine-phosphotriesterase combination in DFP intoxication","volume":"140","author":"Tuovinen","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2019.01.012_bib0790","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.toxlet.2011.02.007","article-title":"Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs","volume":"202","author":"Valiyaveettil","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2019.01.012_bib0795","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.toxlet.2012.01.013","article-title":"Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity","volume":"210","author":"Valiyaveettil","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2019.01.012_bib0800","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0272-0590(91)90183-5","article-title":"Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates","volume":"17","author":"von Bredow","year":"1991","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0805","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0272-0590(91)90185-7","article-title":"Efficacy evaluation of physostigmine and anticholinesterase adjuncts as a pretreatment for nerve agent intoxication","volume":"17","author":"von Bredow","year":"1991","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0810","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"226","author":"Walker","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2019.01.012_bib0815","first-page":"759","article-title":"Case showing the effect of prostigmine on myasthenia gravis","volume":"28","author":"Walker","year":"1934","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.tox.2019.01.012_bib0820","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s11064-011-0564-5","article-title":"[+]-Huperzine A protects against soman toxicity in guinea pigs","volume":"36","author":"Wang","year":"2011","journal-title":"Neurochem. Res."},{"issue":"II","key":"10.1016\/j.tox.2019.01.012_bib0825","first-page":"1243","article-title":"Distribution of memantine in brain, liver, and blood of the rat","volume":"32","author":"Wesemann","year":"1982","journal-title":"Arzneim.-Forsch. Drug Res."},{"issue":"II","key":"10.1016\/j.tox.2019.01.012_bib0830","first-page":"1122","article-title":"Zur Pharmakodynamik und Pharmakokynetik des memantine","volume":"33","author":"Wesemann","year":"1983","journal-title":"Arzneim.-Forsch. Drug Res."},{"key":"10.1016\/j.tox.2019.01.012_bib0835","first-page":"199","article-title":"Determination of human plasma cholinesterase activity by adapted Ellman\u2019s method","volume":"16","author":"Wilhelm","year":"1968","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"10.1016\/j.tox.2019.01.012_bib0840","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0272-0590(87)90048-0","article-title":"Acetylcholinesterase prophylaxis against organophosphate toxicity","volume":"9","author":"Wolfe","year":"1987","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2019.01.012_bib0845","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0272-0590(81)80057-7","article-title":"Problems in the therapy of soman poisoning","volume":"1","author":"Wolthuis","year":"1981","journal-title":"Fundam. Appl. Toxicol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19300617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19300617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:39:57Z","timestamp":1759534797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X19300617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":169,"alternative-id":["S0300483X19300617"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2019.01.012","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic potential of memantine against soman poisoning in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2019.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}